Leveraging the Aggregated Protein Dye YAT2150 for Malaria Chemotherapy
Abstract
Share and Cite
Camarero-Hoyos, C.; Bouzón-Arnáiz, I.; Avalos-Padilla, Y.; Fallica, A.N.; Román-Álamo, L.; Ramírez, M.; Portabella, E.; Cuspinera, O.; Currea-Ayala, D.; Orozco-Quer, M.; et al. Leveraging the Aggregated Protein Dye YAT2150 for Malaria Chemotherapy. Pharmaceutics 2024, 16, 1290. https://doi.org/10.3390/pharmaceutics16101290
Camarero-Hoyos C, Bouzón-Arnáiz I, Avalos-Padilla Y, Fallica AN, Román-Álamo L, Ramírez M, Portabella E, Cuspinera O, Currea-Ayala D, Orozco-Quer M, et al. Leveraging the Aggregated Protein Dye YAT2150 for Malaria Chemotherapy. Pharmaceutics. 2024; 16(10):1290. https://doi.org/10.3390/pharmaceutics16101290
Chicago/Turabian StyleCamarero-Hoyos, Claudia, Inés Bouzón-Arnáiz, Yunuen Avalos-Padilla, Antonino Nicolò Fallica, Lucía Román-Álamo, Miriam Ramírez, Emma Portabella, Ona Cuspinera, Daniela Currea-Ayala, Marc Orozco-Quer, and et al. 2024. "Leveraging the Aggregated Protein Dye YAT2150 for Malaria Chemotherapy" Pharmaceutics 16, no. 10: 1290. https://doi.org/10.3390/pharmaceutics16101290